Dear Colleagues and friends

The importance of prescriptomics and precision medicine in the 21st century is highlighted by the advancements in mass spectrometry, omics technologies, and artificial intelligence. Prescriptomics is an emerging field that focuses on the complex interplay of genetics, proteomics, transcriptomics, metabolomics and epigenetics, and their impact on the effectiveness, safety, and response to prescription medications and precision medicine. This approach goes beyond conventional methods, aiming for a transformative paradigm that enables the precise tailoring of treatment strategies. This leads to minimised adverse effects and optimised therapeutic outcomes, marking a significant shift towards personalized precise medicine

The 1st International Caparica Conference on Prescriptomics and Precision Medicine 2024, scheduled for May 2024 in Caparica, Portugal, is set to feature prominent experts in this field. Plenary speakers include Benedikt Brors from the German Cancer Research Center, Rong Fan from Yale School of Medicine, Anil Korkut from MD Anderson Cancer Center, and Forest White from MIT Center for Precision Cancer Medicine. Keynote speakers such as Nikos Tapinos from Brown University, Russel Rockne from the Beckman Research Institute of City of Hope, Yue Lu from The University of Utah, Albert Grinshpun from Hebrew University- Hadassah Medical School, Ritambhara Singh also from Brown University, and Alexander Xu from Cedars-Sinai Medical Center will also contribute their insights.

The conference will cover various subjects, including the utilization of omics technologies for diagnostic purposes, navigating sample collection and handling techniques, effective patient follow-up strategies, bioinformatics, leveraging AI in enhancing prescription accuracy, precision in prescription management, and insights into point of care devices. This event underscores the rapid evolution and significance of prescriptionomics and precision medicine in contemporary healthcare, emphasizing the role of cutting-edge technologies in advancing this field.

It is important to note that the conference is designed to be an exclusive event, with no more than 150 participants. This deliberate limitation in size ensures that only the pioneers in the field of prescriptomics and precision medicine are present. The goal is to create a focused and high-level environment conducive to fostering new collaborations and establishing teams that will lead future advancements in this groundbreaking area of medical research and practice. This approach underscores the conference’s commitment to driving forward the frontiers of precision medicine and prescriptomics.

 

We look forward to your comments.

Yours truly
J. L. Capelo

C. Lodeiro
Conference chairs
On behalf of the organizing and scientific committee

Plenary Speakers

Benedikt Brors, PhD

German Cancer Research Center, Heidelberg (DKFZ) (Germany)

Rong Fan, PhD

Yale School of Medicine, Yale University (USA)

Anil Korkut, PhD

MD Anderson Cancer Center (USA)

Enabling precision oncology through computational systems biology

Forest White, PhD

MIT Center for Precision Cancer Medicine (USA)

Clinical insights from protein phosphorylation analysis

Nir Peled, PhD

Shaare Zedek Medical Center, Jerusalem (Israel)

The Evolution of Genomic Analysis in Lung Cancer – From Solid to Liquid. Early and Advance Disease

Laura Mercolini, PhD

University of Bologna, Bologna (Italy)

Keynote Speakers

Nikos Tapinos, PhD

Brown University (USA)

Therapeutic targeting of cancer stem cell plasticity

Russel Rockne, PhD

Beckman Research Institute of City of Hope (USA)

Predicting leukemia evolution and response to treatment by integrating transition state theory, machine learning, and the peripheral blood transcriptome

Yue Lu, PhD

The University of Utah (USA)

Albert Grinshpun, PhD

Hebrew University- Hadassah Medical School (Israel)

Ritambhara Singh, PhD

Brown University (USA)

Data-aware modeling and integration in genomics and biomedicine

Alexander Xu, PhD

Cedars-Sinai Medical Center (USA)

Spatial Biology to Predict Survival and Autologous Stem Cell Transplant Response in Hodgkin Lymphoma

Tânia Morais, PhD

University of Lisbon, Lisbon (Portugal)

Microenvironment responsive metallodrugs for precision therapy of FGFR breast cancer

Varda Shoshan-Barmatz, PhD

Ben-Gurion University of the Negev, Beer-Sheva (Israel)

Roberto Mandrioli, PhD

University of Bologna, Bologna (Italy)

Michele Protti, PhD

University of Bologna, Bologna (Italy)

Ivana Pibiri, PhD

University of Palermo, Palermo (Italy)

Tian-Li Wang, PhD

John Hopkins University, Baltimore (USA)

Key advances in molecular classification and novel treatment approaches for ovarian cancer

Symposium Subjects

  • Utilizing Omics Technologies for Diagnostic Purposes
  • Navigating Through Sample Collection and Handling Techniques
  • Strategies for Effective Patient Follow-Up
  • Decoding Biological
  • Data: An Exploration into Bioinformatics
  • Leveraging Artificial Intelligence in Enhancing Prescription Accuracy
  • Approaches to Precision in Prescription Management
  • Innovation at Hand: An Insight into Point of Care Devices

TRYP Lisboa Caparica Mar Hotel

Be aware of cold calls from Convention Hotel Services (CHS) or from someone named Adam Max! A company called CHS (Convention Hotel Services) is calling or e-mailing attendees of conferences worldwide, claiming to work for the conference organizers and asking for credit card details to finalize the booking of accommodation. If you receive such a call or e-mail, do not give away any personal information or credit card details! None of the parties involved in the organization of PRESCRIPTOMICS 2024 is working with CHS

We have received some alerts from participants this week regarding this email: Ehotel Services via DocuSign .

If you receive such a call or e-mail, do not give away any personal information or credit card details! This problem affects many conferences, not only the PROTEOMASS BIOSCOPE conferences.

We look forward to seeing you soon.

With kindest regards

The PROTEOMASS BIOSCOPE Team